- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 9/20 - Pills, lozenges or tablets
Patent holdings for IPC class A61K 9/20
Total number of patents in this class: 13516
10-year publication summary
|
1003
|
1140
|
1252
|
1174
|
1289
|
1275
|
1247
|
1095
|
976
|
276
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
150 |
| Sanovel Ilac Sanayi ve Ticaret A.S. | 257 |
118 |
| Takeda Pharmaceutical Company Limited | 2961 |
104 |
| Boehringer Ingelheim International GmbH | 4629 |
94 |
| Fertin Pharma A/S | 230 |
85 |
| Antecip Bioventures II LLC | 300 |
84 |
| ratiopharm GmbH | 317 |
83 |
| Axsome Therapeutics, Inc. | 213 |
79 |
| Daiichi Sankyo Company, Limited | 1829 |
79 |
| Johnson & Johnson Consumer Inc. | 1277 |
76 |
| Ranbaxy Laboratories Limited | 453 |
73 |
| Purdue Pharma L.P. | 519 |
71 |
| Merck Patent GmbH | 5909 |
67 |
| Hanmi Pharm. Co., Ltd. | 546 |
66 |
| Synthon BV | 308 |
64 |
| Vertex Pharmaceuticals Incorporated | 1581 |
59 |
| Sandoz AG | 1392 |
55 |
| Lupin Limited | 448 |
55 |
| DSM IP Assets B.V. | 5856 |
52 |
| Gilead Sciences, Inc. | 1879 |
51 |
| Other owners | 11951 |